Effectiveness and safety of immunizations in preterm infants;Efficacité et tolérance des vaccinations chez les prématurés

Archives de Pediatrie

Volumn 9, Issue 6, 2002, Pages 629-637

  Francoual, C ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

Immunization; Infant, premature; Vaccines

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; TUBERCULIN; VIRUS VACCINE;

AGE; APNEA; BCG VACCINATION; DIPHTHERIA; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG SAFETY; GESTATIONAL AGE; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HOSPITALIZATION; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INFANT; INFECTION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; MEDICAL LITERATURE; PATIENT MONITORING; PERTUSSIS; POLIOMYELITIS; PRACTICE GUIDELINE; PREMATURITY; REVIEW; RISK FACTOR; TETANUS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUBERCULIN TEST;

EID: 17444451381     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(01)00935-6     Document Type: Short Survey

References (49)

1. Calendrier vaccinal 2000
2. Faut-il vacciner les prématurés?
3. Immunization in special clinical circumstances: Preterm infants
4. Bases immunologiques des vaccinations
5. Immunity in early life: An introduction
6. Studies of immunology of the newborn infants. IV antibody formation in the premature infants
7. Serum immunoglobulin levels in premature and full term infants
8. Évolution des moyens de défense chez l'enfant
9. Arreté du 5 septembre 1996 relatif à la pratique de la vaccination par le vaccin antituberculeux BCG et aux tests tuberculiniques
10. Tuberculin conversion following BCG vaccination in preterm infants
11. Bacille Calmette Guerin vaccination in pre-term infants
12. Avis du Conseil supérieur d'hygiène publique de France du 9 février 2001 relatif à la vaccination contre la coqueluche des nourrissons
13. Studies of the immunology of the newborn infant IV. Antibody formation in the premature infant
14. Response of preterm infants to diphtheria-tetanus, pertussis immunizations
15. Development of the premature infants host defense system and its relationship to routine immunisations
16. Response of preterm infants to diphtheria-tetanus-pertussis vaccine
17. Safety and immunogenicity of a recombinant pertussis vaccine in premature and term infants
18. Safety and immunogenicity of an acelullar pertussis vaccine in premature infants
19. Recommendations of the Advisory Committee on Immunization Practices: Revised recommendations for routine poliomyelitis vaccination
20. Systemic and local immune responses to enhanced-potency inactivated poliovirus vaccine in premature and term infants
21. Early immunization with inactivated poliovirus vaccine in premature infants
22. Immunity to diseases caused by Haemophilus influenzae type b II: Specificity and some biologic characteristics of natural infection acquired and immunization induced antibodies to the capsular polysaccharide of Haemophilus influenzae type b1
23. Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide protein conjugated
24. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study 100 000 vaccines 3 months to 5 years of age in Finland
25. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18 months old infants
26. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants
27. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine
28. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae and polio immunizations
29. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants
30. Thirteenth meeting of global advisory group of EPI
31. Hepatitis B
32. Immune response to hepatitis B vaccine in premature neonates
33. Hepatitis B vaccination and preterm infants
34. Response of preterm infants to hepatitis B vaccine
35. Hepatitis B immunization in infants from HBsAg negative mothers
36. Immune response of preterm infants to hepatitis B vaccine
37. Immunogenicity of hepatitis B Vaccine in preterm infants
38. Immunogenicity of hepatitis B vaccine in preterm infants
39. Hepatitis B. Vaccination of premature infants. A reassessment of current recommendation for delayed immunization
40. Immune response of premature infants to meningococcal serogroup C and combined diphteria-tetanus toxoids, acellular pertussis, Haemophilus influenzae type b conjugate vaccine
41. Influenza
42. Immune responses of prematurely born infants to hepatitis B vaccination: Results through three years of age
43. Three year follow-up of vaccine response in extremely preterm infants
44. The preterm infant's long-term immune response to a combined diphteria, tetanus, acellular pertussis and hepatitis B vaccine
45. Routine immunisation of preterm infants
46. Immunisation of the preterm baby
47. Apnea after immunization of preterm infants
48. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status